Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ibio Inc (IBIO)

Ibio Inc (IBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 355,096
  • Shares Outstanding, K 217,850
  • Annual Sales, $ 1,640 K
  • Annual Income, $ -16,440 K
  • 60-Month Beta -6.21
  • Price/Sales 210.14
  • Price/Cash Flow N/A
  • Price/Book 3.07
Trade IBIO with:

Options Overview

Details
  • Implied Volatility 137.38%
  • Historical Volatility 60.47%
  • IV Percentile 20%
  • IV Rank 18.28%
  • IV High 316.25% on 07/30/20
  • IV Low 97.37% on 04/22/21
  • Put/Call Vol Ratio 0.11
  • Today's Volume 4,039
  • Volume Avg (30-Day) 4,072
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 104,193
  • Open Int (30-Day) 92,973

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2737 +27.97%
on 05/19/21
1.7550 -7.12%
on 06/10/21
-0.0200 (-1.21%)
since 05/11/21
3-Month
1.1700 +39.32%
on 04/19/21
1.9500 -16.41%
on 05/07/21
-0.1500 (-8.43%)
since 03/11/21
52-Week
1.0300 +58.25%
on 12/31/20
7.4500 -78.12%
on 07/21/20
+0.2300 (+16.43%)
since 06/11/20

Most Recent Stories

More News
Thinking about buying stock in Vaxart, Graybug Vision, Jaguar Health, iBio, or Aptinyx?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VXRT, GRAY, JAGX, IBIO, and APTX.

IBIO : 1.6300 (+3.16%)
APTX : 3.50 (+9.03%)
GRAY : 5.87 (+6.15%)
VXRT : 8.74 (+21.90%)
JAGX : 1.9100 (unch)
iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, announced today the appointment of Evert (Eef) Schimmelpennink to its Board of...

PFNX : 12.75 (-0.08%)
IBIO : 1.6300 (+3.16%)
Global C1 Inhibitors Market Share at 18.6% CAGR Expected to Generate Revenue of USD 9,800 Million by 2026: Facts & Factors

Facts and Factors have published a new research report titled "C1 Inhibitors Market By Source (Human Derived & Recombinant Derived C1 Inhibitors), By Mode of Administration (Intravenous & Subcutaneous),...

IBIO : 1.6300 (+3.16%)
IONS : 37.93 (-0.73%)
iBio to Present at the UBS Global Healthcare Virtual Conference

iBio, Inc. (NYSE:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, announced today that management will present an update on the Company's business...

IBIO : 1.6300 (+3.16%)
iBio: Buy or Sell?

Even though biotechnology company iBio (IBIO) reported some positive developments related to its COVID-19 vaccine candidates this month, it is way behind competitors that are already distributing COVID-19...

IBIO : 1.6300 (+3.16%)
iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today announced its financial results for the fiscal quarter ended March 31, 2021....

IBIO : 1.6300 (+3.16%)
iBio, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 17, 2021 / iBio, Inc. (NYSE:IBIO) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on May 17, 2021 at 8:00 AM Eastern Time....

IBIO : 1.6300 (+3.16%)
iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update on Monday, May 17, 2021

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, announced today that it will report its fiscal 2021 third quarter financial results...

IBIO : 1.6300 (+3.16%)
Thinking about buying stock in iBio, T2 Biosystems, Viewray, GoPro, or Tilray?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IBIO, TTOO, VRAY, GPRO, and TLRY.

IBIO : 1.6300 (+3.16%)
GPRO : 12.59 (+6.07%)
TLRY : 19.89 (-0.80%)
TTOO : 1.4000 (+1.45%)
VRAY : 5.81 (+0.87%)
iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program

iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company"), a biotech innovator and biologics contract manufacturing organization, today provided an update on its IBIO-201 program and reported on its progress in...

IBIO : 1.6300 (+3.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture...

See More

Key Turning Points

3rd Resistance Point 1.7567
2nd Resistance Point 1.7033
1st Resistance Point 1.6667
Last Price 1.6300
1st Support Level 1.5767
2nd Support Level 1.5233
3rd Support Level 1.4867

See More

52-Week High 7.4500
Fibonacci 61.8% 4.9976
Fibonacci 50% 4.2400
Fibonacci 38.2% 3.4824
Last Price 1.6300
52-Week Low 1.0300

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar